✦ LIBER ✦

microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway

✍ Scribed by Cui, Wenjing; Zhang, Shuai; Shan, Changliang; Zhou, Li; Zhou, Zhemin

Book ID: 121219000
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 823 KB
Volume: 280
Category: Article
ISSN: 1432-1327
DOI: 10.1111/febs.12398

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

microRNA-133 inhibits cell proliferation

microRNA-133 inhibits cell proliferation, migration and invasion in prostate cancer cells by targeting the epidermal growth factor receptor

✍ Lu, Qiang 📂 Article 📅 2012 🏛 Spandidos Publications Ltd 🌐 English ⚖ 653 KB

Benzo[a]pyrene promotes proliferation of

Benzo[a]pyrene promotes proliferation of human lung cancer cells by accelerating the epidermal growth factor receptor signaling pathway

✍ Takuro Kometani; Ichiro Yoshino; Naoko Miura; Hiroshi Okazaki; Taro Ohba; Tomoyo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 549 KB

Targeted inhibition of the epidermal gro

Targeted inhibition of the epidermal growth factor receptor-tyrosine kinase by ZD1839 (‘Iressa’) induces cell-cycle arrest and inhibits proliferation in prostate cancer cells

✍ Alessandro Sgambato; Andrea Camerini; Beatrice Faraglia; Raffaele Ardito; Gabrie 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 2 views

## Abstract The epidermal growth factor (EGF) plays a role in the development of prostate cancer, which becomes essential after androgen resistance has emerged. The EGF receptor (EGFR) is therefore a potential target for anticancer therapy. We evaluated the effects of ZD1839 (‘Iressa’), an orally a

Inhibition of proliferation and inductio

Inhibition of proliferation and induction of apoptosis in breast cancer cells by the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ZD1839 (‘Iressa’) is independent of EGFR expression level

✍ Manuela Campiglio; Alberta Locatelli; Clelia Olgiati; Nicola Normanno; Giulia So 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 2 views

High expression of the epidermal growth factor receptor (EGFR) in breast carcinoma confers a growth advantage to the tumor cells. The EGFR tyrosine kinase inhibitor (EGFR-TKI) ZD1839 ('Iressa') has clinical activity in a wide range of tumor types, although the mechanism(s) by which it exerts its ant